These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 16787662)

  • 21. Outcome of patients who develop acute leukemia or myelodysplasia as a second malignancy after solid tumors treated surgically or with strategies that include chemotherapy and/or radiation.
    Abdelhameed A; Pond GR; Mitsakakis N; Brandwein J; Chun K; Gupta V; Kamel-Reid S; Lipton JH; Minden MD; Schimmer A; Schuh A; Yee K; Messner HA
    Cancer; 2008 Apr; 112(7):1513-21. PubMed ID: 18286528
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Estimating the prevalence of myelodysplastic syndromes in patients with unexplained cytopenias: a retrospective study of 322 bone marrows.
    Buckstein R; Jang K; Friedlich J; Zhang L; Reis M; Chesney A; Wells RA
    Leuk Res; 2009 Oct; 33(10):1313-8. PubMed ID: 19282029
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Myelodysplastic syndromes. The epidemiological and etiological aspects].
    Aul C; Gattermann N; Germing U; Runde V; Heyll A
    Dtsch Med Wochenschr; 1992 Aug; 117(33):1223-31. PubMed ID: 1499520
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pregnancy in patients with myelodysplastic syndromes (MDS).
    Volpicelli P; Latagliata R; Breccia M; Carmosino I; Stefanizzi C; Napoleone L; Vozella F; Levi A; Natalino F; Alimena G
    Leuk Res; 2008 Oct; 32(10):1605-7. PubMed ID: 18374412
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Myelodysplastic syndromes associated with interstitial deletion of chromosome 5q: clinicopathologic correlations and new insights from the pre-lenalidomide era.
    Holtan SG; Santana-Davila R; Dewald GW; Khetterling RP; Knudson RA; Hoyer JD; Chen D; Hanson CA; Porrata L; Tefferi A; Steensma DP
    Am J Hematol; 2008 Sep; 83(9):708-13. PubMed ID: 18634051
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prevalence of MDS subtypes in Shanghai, China: a comparison of the World Health Organization and French American British classifications.
    Irons RD; Wang X; Gross SA; Bao L; Ryder J; Chen Y; Chen H; Sun H; Zhou J; Ji M; Du X; Fu H; Lin G
    Leuk Res; 2006 Jul; 30(7):769-75. PubMed ID: 16337268
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Increased incidence of acute myeloid leukemia after liver transplantation? Description of three new cases and review of the literature.
    Camós M; Esteve J; Rimola A; Grande L; Rozman M; Colomer D; Villamor N; Costa D; Montserrat E
    Transplantation; 2004 Jan; 77(2):311-3. PubMed ID: 14743000
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Secondary myelodysplastic syndrome after hydroxychloroquine therapy.
    Muslimani AA; Spiro TP; Chaudhry AA; Daw HA
    Ann Hematol; 2007 Jul; 86(7):531-4. PubMed ID: 17205285
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Myeloid Neoplasms Following Solid Organ Transplantation: Clinicopathologic Studies of 23 Cases.
    Wu B; Ingersoll K; Jug R; Yang LH; Luedke C; Lo A; Su P; Liu X; Rehder C; Gong J; Lu CM; Wang E
    Am J Clin Pathol; 2017 Dec; 149(1):55-66. PubMed ID: 29228125
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Predictors of outcome following myeloablative allo-SCT for therapy-related myelodysplastic syndrome and AML.
    Nevill TJ; Hogge DE; Toze CL; Nantel SH; Power MM; Abou Mourad YR; Song KW; Lavoie JC; Forrest DL; Barnett MJ; Shepherd JD; Nitta JY; Wong S; Sutherland HJ; Smith CA
    Bone Marrow Transplant; 2008 Nov; 42(10):659-66. PubMed ID: 18679372
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Intensive chemotherapy is not recommended for patients aged >60 years who have myelodysplastic syndromes or acute myeloid leukemia with high-risk karyotypes.
    Knipp S; Hildebrand B; Kündgen A; Giagounidis A; Kobbe G; Haas R; Aul C; Gattermann N; Germing U
    Cancer; 2007 Jul; 110(2):345-52. PubMed ID: 17559141
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sustained remissions of high-risk acute myeloid leukemia and myelodysplastic syndrome after reduced-intensity conditioning allogeneic hematopoietic transplantation: chronic graft-versus-host disease is the strongest factor improving survival.
    Valcárcel D; Martino R; Caballero D; Martin J; Ferra C; Nieto JB; Sampol A; Bernal MT; Piñana JL; Vazquez L; Ribera JM; Besalduch J; Moraleda JM; Carrera D; Brunet MS; Perez-Simón JA; Sierra J
    J Clin Oncol; 2008 Feb; 26(4):577-84. PubMed ID: 18086801
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Issues in the pathology of the myelodysplastic syndromes.
    Kampmeier P; Anastasi J; Vardiman JW
    Hematol Oncol Clin North Am; 1992 Jun; 6(3):501-22. PubMed ID: 1613003
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hypocellularity in myelodysplastic syndrome is an independent factor which predicts a favorable outcome.
    Yue G; Hao S; Fadare O; Baker S; Pozdnyakova O; Galili N; Woda BA; Raza A; Wang SA
    Leuk Res; 2008 Apr; 32(4):553-8. PubMed ID: 17888511
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Biological and clinical relevance of matrix metalloproteinases 2 and 9 in acute myeloid leukaemias and myelodysplastic syndromes.
    Travaglino E; Benatti C; Malcovati L; Della Porta MG; Gallì A; Bonetti E; Rosti V; Cazzola M; Invernizzi R
    Eur J Haematol; 2008 Mar; 80(3):216-26. PubMed ID: 18081721
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Prospective clinical study of diagnosis and classification for 282 cases with primary myelodysplastic syndrome].
    Wang XQ;
    Zhonghua Xue Ye Xue Za Zhi; 2006 Aug; 27(8):546-9. PubMed ID: 17172130
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Extramedullary initial manifestations of acute myeloid leukemia (AML)].
    Schmitt-Gräff A; Wickenhauser C; Kvasnicka HM; Dries V; Thiele J
    Pathologe; 2002 Nov; 23(6):397-404. PubMed ID: 12436291
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The evolution of hematopoietic SCT in myelodysplastic syndrome.
    Kindwall-Keller T; Isola LM
    Bone Marrow Transplant; 2009 Apr; 43(8):597-609. PubMed ID: 19252532
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Time to engraftment following allogeneic stem cell transplantation is significantly longer in patients with myelodysplastic syndrome than with acute myeloid leukemia.
    Bitan M; Or R; Shapira MY; Resnick IB; Gesundheit B; Ackerstein A; Samuel S; Elad S; Slavin S
    Bone Marrow Transplant; 2008 Jan; 41(1):69-78. PubMed ID: 17994125
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Distribution of cytogenetic abnormalities in myelodysplastic syndromes, Philadelphia negative myeloproliferative neoplasms, and the overlap MDS/MPN category.
    Bacher U; Schnittger S; Kern W; Weiss T; Haferlach T; Haferlach C
    Ann Hematol; 2009 Dec; 88(12):1207-13. PubMed ID: 19415278
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.